<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10091358</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad021</article-id>
    <article-id pub-id-type="publisher-id">baad021</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>NbThermo: a new thermostability database for nanobodies</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1291-1587</contrib-id>
        <name>
          <surname>Valdés-Tresanco</surname>
          <given-names>Mario S</given-names>
        </name>
        <!--mariosergiovaldes145@gmail.com-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Faculty of Basic Sciences, University of Medellin</institution>, Cra. 87 No. 30-65, Medellin 050026, <country country="CO">Colombia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9625-6988</contrib-id>
        <name>
          <surname>Valdés-Tresanco</surname>
          <given-names>Mario E</given-names>
        </name>
        <aff><institution content-type="department">Centre for Molecular Simulations and Department of Biological Sciences, University of Calgary</institution>, 2500 University Drive N.W, Calgary, AB T2N 1N4, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Molina-Abad</surname>
          <given-names>Esteban</given-names>
        </name>
        <aff><institution>Globant S.A.</institution>, Av. El Poblado #5A 113, Medellin 050021, <country country="CO">Colombia</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2309-4826</contrib-id>
        <name>
          <surname>Moreno</surname>
          <given-names>Ernesto</given-names>
        </name>
        <!--emoreno@udemedellin.edu.co-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Faculty of Basic Sciences, University of Medellin</institution>, Cra. 87 No. 30-65, Medellin 050026, <country country="CO">Colombia</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Email: <email xlink:href="mariosergiovaldes145@gmail.com">mariosergiovaldes145@gmail.com</email>Correspondence may also be addressed to Ernesto Moreno. Email: <email xlink:href="emoreno@udemedellin.edu.co">emoreno@udemedellin.edu.co</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-04-12">
      <day>12</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <volume>2023</volume>
    <elocation-id>baad021</elocation-id>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>08</day>
        <month>2</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>16</day>
        <month>3</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>13</day>
        <month>3</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>12</day>
        <month>4</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad021.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>We present NbThermo—a first-in-class database that collects melting temperatures (<italic toggle="yes">T</italic><sub>m</sub>), amino acid sequences and several other categories of useful data for hundreds of nanobodies (Nbs), compiled from an extensive literature search. This so-far unique database currently contains up-to-date, manually curated data for 564 Nbs. It represents a contribution to efforts aimed at developing new algorithms for reliable <italic toggle="yes">T</italic><sub>m</sub> prediction to assist Nb engineering for a wide range of applications of these unique biomolecules. Nbs from the two most common source organisms—llama and camel—show similar distributions of melting temperatures. A first exploratory research that takes advantage of this large data collection evidences that understanding the structural bases of Nb thermostability is a complex task, since there are no apparent differences in sequence patterns between the frameworks of Nbs with lower and higher melting temperatures, indicating that the highly variable loops play a relevant role in defining Nb thermostability.</p>
      <p>
        <bold>Database URL</bold>
        <ext-link xlink:href="https://valdes-tresanco-ms.github.io/NbThermo" ext-link-type="uri">https://valdes-tresanco-ms.github.io/NbThermo</ext-link>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>MINCIENCIAS, MINEDUCACIÓN, MINCIT and ICETEX, through the Program NanoBioCáncer</institution>
          </institution-wrap>
        </funding-source>
        <award-id>FP44842-211-2018</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s2">
    <title>Introduction</title>
    <p>Heavy-chain antibodies (HCAbs), commonly known as nanobodies (Nbs), have been gaining ground in the therapeutic and diagnostic areas since their discovery three decades ago. Common Nb applications include therapeutic uses in cancer and other diseases, <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> diagnosis, identification of molecular targets, drug delivery and as chaperone molecules in protein crystallography, among many others (<xref rid="R1" ref-type="bibr">1–4</xref>). Such versatility finds support in the unique structural characteristics of Nbs, such as the high thermal and reductive stabilities that allow their expression both extra- and intracellularly, their small size favoring tissue penetration, easy engineering allowing the generation of multimeric constructs, low immunogenicity due to their high similarity to the variable heavy domains of human antibodies and versatility in antigen recognition (<xref rid="R5" ref-type="bibr">5–7</xref>).</p>
    <p>Intrinsic stability is of particular importance for the construction of synthetic Nb libraries (<xref rid="R8" ref-type="bibr">8</xref>), as well as for <italic toggle="yes">in vitro</italic> affinity maturation and the engineering of these molecules in general. Several studies have been performed aiming to understand both sequence and structural factors related to Nb stability, especially thermostability as measured through the melting temperature (<italic toggle="yes">T</italic><sub>m</sub>) (<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R9" ref-type="bibr">9–14</xref>), which is the temperature at which approximately 50% of the protein molecules are unfolded. This property is closely related to other attributes such as solubility and cell production. Thus, various studies have shown that mutation of one or several residues can increase <italic toggle="yes">T</italic><sub>m</sub> but drastically decrease yield (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>), while in other cases, it can affect the affinity for the antigen (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R17" ref-type="bibr">17–20</xref>).</p>
    <p>The scarce availability of thermostability data for Nbs makes it difficult to generate algorithms to predict their <italic toggle="yes">T</italic><sub>m</sub>. Currently, several Nb databases have been reported, such as the ‘Integrated Nanobody Database for Immunoinformatics’ (<xref rid="R21" ref-type="bibr">21</xref>), SAbDab-nano (<xref rid="R22" ref-type="bibr">22</xref>), CoV-AbDab (<xref rid="R23" ref-type="bibr">23</xref>) and the ‘Institute Collection and Analysis of Nanobodies’ (iCAN) (<xref rid="R24" ref-type="bibr">24</xref>). These databases are focused mainly on sequences and crystallographic structures, although CoV-AbDab and iCAN also contain data on antigens and binding affinities. In this work, we present NbThermo—the first database that collects thermostabilty data for hundreds of Nb, together with amino acid sequences, 3D structures and other data that we considered important for studies that aim to understand the determinants of Nb stability.</p>
  </sec>
  <sec id="s3">
    <title>Methods</title>
    <sec id="s3-s1">
      <title>Data collection</title>
      <p>We started with an exhaustive search of the available literature in PubMed and Google Scholar, using the following keywords: VHH, sdAbs, sybody, nanobody, HCAb, single domain antibody, antibody fragment, thermal stability and melting. With these keywords, we attempted to collect all the publications containing together any of the terms used for Nbs and thermostability data. Our search covered the time interval between 1993 (the year when HCAbs in camelids were first reported) and 10 October 2022.</p>
      <p>The following data were compiled for each database entry:</p>
      <list list-type="roman-lower">
        <list-item>
          <p>Name of the Nb.</p>
        </list-item>
        <list-item>
          <p>Reference DOI.</p>
        </list-item>
        <list-item>
          <p>Crystallographic structure (Protein Data Bank entry) when available.</p>
        </list-item>
        <list-item>
          <p>Melting temperature (<italic toggle="yes">T</italic><sub>m</sub>), subclassified according to the employed experimental method: nano differential scanning fluorimetry (nanoDSF), DSF with SYPRO Orange, differential scanning calorimetry (DSC), circular dichroism (CD) + refolding and ‘Other’ for methods not mentioned earlier.</p>
        </list-item>
        <list-item>
          <p>Antigen, with the following fields: name, type and affinity.</p>
        </list-item>
        <list-item>
          <p>Cell production, subclassified according to the cellular location: periplasm, cytoplasm, and other for those without this information.</p>
        </list-item>
        <list-item>
          <p>Origin, subclassified into source for the organism (generic name, includes synthetic and unknown); type, according to whether the Nb is natural, fully synthetic or semi-synthetic; and obtaining method, which comprises immunization, naive, point mutation or other modification procedures.</p>
        </list-item>
        <list-item>
          <p>Sequence, with the following fields: raw sequence, sequence numbered using the Aho scheme (<xref rid="R25" ref-type="bibr">25</xref>), framework (Fw) and complementarity-determining regions (CDRs), labeled as follows: Fw1, CDR1, Fw2, CDR2, Fw3, CDR3, Fw4.</p>
        </list-item>
      </list>
    </sec>
    <sec id="s3-s2">
      <title>Annotations</title>
      <p>Data found in text mode (e.g. Nb name, antigen name, DOI, sequence, etc.) were copied manually directly from the sources. Most of the sequences reported in the literature are found as images, and therefore, an online optical character recognition-to-text conversion tool (<ext-link xlink:href="https://www.ocr2edit.com/convert-to-txt" ext-link-type="uri">https://www.ocr2edit.com/convert-to-txt</ext-link>) was used, followed by a careful visual inspection of the obtained text. Each sequence, as well as mutant constructs whose sequences were not explicitly reported, was thoroughly checked. Likewise, antigen data such as affinity values (<italic toggle="yes">K</italic><sub>D</sub>—dissociation constant) as well as <italic toggle="yes">T</italic><sub>m</sub> and expression yields were manually annotated from tables in research articles and supplementary materials. <italic toggle="yes">K</italic><sub>D</sub> values were standardized in nanomolar (nM), while the expression yields were standardized in mg/l. The amino acid sequences were numbered according to the Aho scheme (<xref rid="R25" ref-type="bibr">25</xref>) using the ANARCI tool (<xref rid="R26" ref-type="bibr">26</xref>).</p>
    </sec>
    <sec id="s3-s3">
      <title>Implementation of NbThermo</title>
      <p>A static website hosted on GitHub (<ext-link xlink:href="https://github.com/" ext-link-type="uri">https://github.com/</ext-link>) was created to implement and provide free access to NbThermo (<ext-link xlink:href="https://valdes-tresanco-ms.github.io/NbThermo" ext-link-type="uri">https://valdes-tresanco-ms.github.io/NbThermo</ext-link>). The frontend for this project was generated using Angular CLI version 13.2.4 (<ext-link xlink:href="https://angular.io/cli" ext-link-type="uri">https://angular.io/cli</ext-link>).</p>
    </sec>
  </sec>
  <sec id="s4">
    <title>Results</title>
    <sec id="s4-s1">
      <title>General overview</title>
      <p>The literature search yielded ca. 1200 articles, which were all reviewed. As result, we collected data on 564 Nbs, found in 65 publications.</p>
    </sec>
    <sec id="s4-s2">
      <title>Melting temperature</title>
      <p>For each Nb, <italic toggle="yes">T</italic><sub>m</sub> is reported with also the experimental method used for its measurement. In several cases, different values are reported for two or more experimental methods, for the same Nb. The method with the highest representation is CD, followed by DSF with SYPRO Orange, nanoDSF, DSC and a few cases where the experimental method is not reported (<xref rid="F1" ref-type="fig">Figure 1A</xref>).</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p><italic toggle="yes">T</italic><sub>m</sub> data in the NbThermo database. (A) Distribution of <italic toggle="yes">T</italic><sub>m</sub> measurements by experimental methods: CD, DSF with SYPRO Orange, nanoDSF and DSC. (B) Distribution of <italic toggle="yes">T</italic><sub>m</sub> values as measured using different experimental methods. The box represents the interquartile range, the horizontal line within the box represents the median and the bottom and upper lines account for the minimum and maximum <italic toggle="yes">T</italic><sub>m</sub>, respectively. (C) Distribution of <italic toggle="yes">T</italic><sub>m</sub> values across the database, showing with stacked bars the use of the different experimental methods. The median value is highlighted by a vertical dashed line.</p>
        </caption>
        <graphic xlink:href="baad021f1" position="float"/>
      </fig>
      <p>In most cases where <italic toggle="yes">T</italic><sub>m</sub> was measured using CD, the refolding ratio (secondary structure recovery) is also reported, evidencing that Nbs with high melting temperatures regain most of their secondary structure, with only a very few exceptions (data not shown). While <italic toggle="yes">T</italic><sub>m</sub> experiments using CD require specialized equipment, which limits its use, DSF with SYPRO Orange is more accessible since it can be performed with real-time PCR (RT-PCR) equipment and can cover a similarly broad <italic toggle="yes">T</italic><sub>m</sub> range (<xref rid="F1" ref-type="fig">Figure 1B</xref>). Unlike with CD, Nb denaturalization with the SYPRO Orange reagent is irreversible, since it binds to the hydrophobic core of the structure. This is why using this method, it is not possible to measure the refolding ratio, but nonetheless, due to its higher accessibility, lower costs and ease of execution, its use for <italic toggle="yes">T</italic><sub>m</sub> determination is increasing.</p>
      <p>Individually, the different experimental methods for <italic toggle="yes">T</italic><sub>m</sub> measurement show similar medians across the database: 69, 67, 67, 60 and 64°C, for CD, DSF (SYPRO), nanoDSF, DSC and ‘Other’, respectively (<xref rid="F1" ref-type="fig">Figure 1B</xref>). Considering all the experimental methods, <italic toggle="yes">T</italic><sub>m</sub> is in the range from 39 to 98°C, with a median of 67.2°C (<xref rid="F1" ref-type="fig">Figure 1C</xref>).</p>
    </sec>
    <sec id="s4-s3">
      <title>Nb origin and sequence</title>
      <p>The database contains a wide variety of Nbs, coming mainly from llamas (302) and camels (175) (<xref rid="F2" ref-type="fig">Figure 2A</xref>). The variable domains of the new antigen receptor of sharks, also included in the database, differ in sequence from camelid Nbs. Most of the reported Nbs are of natural origin, obtained from immune or naïve libraries (<xref rid="F2" ref-type="fig">Figure 2B</xref>). Here, we have regarded as semi-synthetic all Nbs with at least one engineered modification, such as point mutations or tail additions (<xref rid="F2" ref-type="fig">Figure 2B</xref>). It is worth noting that, although an N- or C-terminal addition does not modify the Nb sequence, it does have an effect on <italic toggle="yes">T</italic><sub>m</sub>. The Nbs in the database were obtained by multiple methods, with the most common being immunization and site-directed mutagenesis (point mutations) (<xref rid="F2" ref-type="fig">Figure 2C</xref>). Animal immunization has been a widely used method to obtain high affinity binders, for which <italic toggle="yes">T</italic><sub>m</sub> is reported as stability data. Introducing point mutations in some structures, on the other hand, aims at improving Nb–antigen affinity (<italic toggle="yes">in vitro</italic> affinity maturation) and/or improving other properties such as thermostability, solubility or cell production (<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>).</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Distribution of Nbs in the database according to (A) source (organism), (B) type and (C) obtaining method.</p>
        </caption>
        <graphic xlink:href="baad021f2" position="float"/>
      </fig>
      <p>Manual annotation and revision of the amino acid sequences were undoubtedly the most complex task in the construction of this database. All the original sequences, including those with various tails such as His, Myc and Hop tags, were annotated. In addition, the Nb sequences were numbered according to the Aho scheme (<xref rid="R25" ref-type="bibr">25</xref>), which we selected among others mainly because it distributes the amino acids symmetrically around the gaps in the CDRs, thus piling up in the alignment those amino acids that are structurally close. This is useful especially for phylogenetic analyses of positional amino acid conservation/variation. Other numbering schemes will be added in the future.</p>
      <p>For each sequence, we also annotated the lengths of its three CDRs. While CDR1 and CDR2 do not show important length variations (data not shown), CDR3 lengths span a wide range, from 3 to 26 amino acids, with lengths 15, 16 and 17 being the most represented in the database (<xref rid="F3" ref-type="fig">Figure 3</xref>), similarly as reported in the recently published ‘Integrated nanobody database for immunoinformatics’ (<xref rid="R21" ref-type="bibr">21</xref>).</p>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Distribution of CDR3 lengths in the database by source organism.</p>
        </caption>
        <graphic xlink:href="baad021f3" position="float"/>
      </fig>
    </sec>
    <sec id="s4-s4">
      <title>Other annotations</title>
      <p>NbThermo includes also data related to Nb engineering. While mutations in the Fw region would rather not affect the affinity, mutations generated in the <italic toggle="yes">in vitro</italic> affinity maturation process may affect thermostability. We then included annotations on reported antigens (mostly of protein nature) and their affinities. Furthermore, some mutations can affect cell production, and therefore, we also included these data when available.</p>
    </sec>
    <sec id="s4-s5">
      <title>Implementation as website</title>
      <p>NbThermo is freely available on its website (<ext-link xlink:href="https://valdes-tresanco-ms.github.io/NbThermo" ext-link-type="uri">https://valdes-tresanco-ms.github.io/NbThermo</ext-link>) and in the repository (<ext-link xlink:href="https://github.com/Valdes-Tresanco-MS/NbThermo" ext-link-type="uri">https://github.com/Valdes-Tresanco-MS/NbThermo</ext-link>). The graphical interface contains two panels (<xref rid="F4" ref-type="fig">Figure 4</xref>): the left panel shows annotation filters (left) and the right panel shows the selection list and the annotated information, where the information corresponding to the selected Nbs is given. The filter panel allows the user to explore on the fly amino acid sequences, <italic toggle="yes">T</italic><sub>m</sub> ranges, experimental methods, antigens and any other field in the database.</p>
      <fig position="float" id="F4" fig-type="figure">
        <label>Figure 4.</label>
        <caption>
          <p>Snapshot of the NbThermo database interface. The left panel contains the annotation filters, while the right panel displays the selection list and the annotated information corresponding to the selected Nbs.</p>
        </caption>
        <graphic xlink:href="baad021f4" position="float"/>
      </fig>
      <p>For each selected Nb, the data registered in the database are shown in the form of cards. In the same way, the <italic toggle="yes">T</italic><sub>m</sub> for the selected entry is highlighted in the <italic toggle="yes">T</italic><sub>m</sub> distribution graph of all the registered Nbs. Furthermore, users can access the original sequence, with its both sequential and Aho numbering schemes and information on the CDR and Fw regions. Finally, if available in the Protein Data Bank, the Nb three-dimensional structure can be inspected with an embedded molecular visualizer.</p>
    </sec>
    <sec id="s4-s6">
      <title>Exploring possible determinants of Nb thermostability</title>
      <p>As an exploratory analysis of the data compiled in NbThermo, we set to investigate three questions of scientific and practical relevance, counting now with a richer source of data to support the analyses.</p>
      <sec id="s4-s6-s1">
        <title>Q1—are there differences in the thermostability distribution for Nbs belonging to distinct species?</title>
        <p>In a study by Kunz <italic toggle="yes">et al.</italic>, carried out with a dataset of 78 Nbs (camel—57, llama—17, alpaca—4, all of them of natural origin according to our classification), it was noted that llama Nbs tend to have a higher median <italic toggle="yes">T</italic><sub>m</sub> compared to camel Nbs (<xref rid="R9" ref-type="bibr">9</xref>). Performing a similar analysis in NbThermo yields the opposite result, although with a minor difference. Natural Nbs from camels show a higher median <italic toggle="yes">T</italic><sub>m</sub> (66 vs. 64°C for llama Nbs). However, if we include also Nbs of other origins, the overall medians for camel and llama Nbs are close to each other (camel <italic toggle="yes">T</italic><sub>m median</sub> = 68.5°C; llama <italic toggle="yes">T</italic><sub>m median</sub> = 68.0°C), followed by the median <italic toggle="yes">T</italic><sub>m</sub> values for alpacas and sharks (66 and 62°C, respectively) (<xref rid="F5" ref-type="fig">Figure 5</xref>). Noteworthily, all organisms show a similar distribution around the overall database mean <italic toggle="yes">T</italic><sub>m</sub> value (67°C) (<xref rid="s7" ref-type="sec">Figure S1</xref>). Since the difference between the median <italic toggle="yes">T</italic><sub>m</sub> of camels and llamas is small (2°C), the selection of one or the other species as a source of Nbs would be rather determined by other factors such as production costs.</p>
        <fig position="float" id="F5" fig-type="figure">
          <label>Figure 5.</label>
          <caption>
            <p>Distribution of <italic toggle="yes">T</italic><sub>m</sub> values by Nb: source and type.</p>
          </caption>
          <graphic xlink:href="baad021f5" position="float"/>
        </fig>
      </sec>
      <sec id="s4-s6-s2">
        <title>Q2—is there a correlation between thermostability and CDR3 length?</title>
        <p>We hypothesized that Nbs having longer CDR3, which are mostly bent over a Fw surface area that in classical antibodies interacts with the variable light domain, would show higher <italic toggle="yes">T</italic><sub>m</sub> values precisely because of the CDR3 packing against the Fw. However, only a poor correlation was obtained, which was slightly higher for camel Nbs (<xref rid="s7" ref-type="sec">Figure S2</xref>). These results are similar to those obtained by Kunz <italic toggle="yes">et al.</italic> (<xref rid="R7" ref-type="bibr">7</xref>) using a smaller dataset.</p>
      </sec>
      <sec id="s4-s6-s3">
        <title>Q3—are there different sequence patterns among the frameworks of Nbs with low and high thermostabilities?</title>
        <p>Identifying sequence patterns in the Fw that would confer high thermostability to Nbs based on such Fws is of outmost importance for Nb engineering, particularly for the design of synthetic libraries. Here, we compared, both for camel and llama Nbs, two groups of Fw sequences having separated ranges of melting temperature: <italic toggle="yes">T</italic><sub>m</sub> ≤ 60°C and <italic toggle="yes">T</italic><sub>m</sub> ≥ 75°C. For each group, we extracted the consensus Fw sequence (<xref rid="F6" ref-type="fig">Figure 6</xref>).</p>
        <fig position="float" id="F6" fig-type="figure">
          <label>Figure 6.</label>
          <caption>
            <p>Llama and camel consensus Fw sequences for the low- and high-<italic toggle="yes">T</italic><sub>m</sub> groups. The white spaces correspond to the three CDRs. Sequence positions differing between the two groups of the same species are marked with an asterisk.</p>
          </caption>
          <graphic xlink:href="baad021f6" position="float"/>
        </fig>
        <p>Interestingly, only four differences in the consensus Fw sequences (E1Q, Q5V, A6E and Y28F) were found between the low- and high-<italic toggle="yes">T</italic><sub>m</sub> llama groups, while only two differences were found for the camel groups (Q5V and W38G). It has been shown that even a single mutation may cause a considerable <italic toggle="yes">T</italic><sub>m</sub> variation; however, these few differences in consensus sequence can hardly explain the <italic toggle="yes">T</italic><sub>m</sub> differences between the low- and high-<italic toggle="yes">T</italic><sub>m</sub> groups since the differing amino acids are present in both groups (<xref rid="s7" ref-type="sec">Figure S3</xref>). For example, in camel Nbs, both tryptophan and glycine are found at position 38 in both the low- and high-<italic toggle="yes">T</italic><sub>m</sub> groups, although at different frequencies. Interestingly, comparison of the consensus sequences between the high- <italic toggle="yes">T</italic><sub>m</sub> groups in llama and camel shows that they differ by the same number of positions as the high- and low-<italic toggle="yes">T</italic><sub>m</sub> groups in llama (<xref rid="s7" ref-type="sec">Table S1</xref>).</p>
        <p>These findings indicate that the Fw structure alone does not define Nb thermostability, implying that the CDRs make an essential contribution. In particular, the interaction between CDR3 and the Fw may play a significant role, as found in a recent study by Kinoshita <italic toggle="yes">et al.</italic>, showing that mutations of amino acids at this interface can cause a considerable <italic toggle="yes">T</italic><sub>m</sub> decrease (<xref rid="R27" ref-type="bibr">27</xref>). Thus, the so-called ‘universality’ of a Fw, relevant for synthetic library construction, would then rely on the Fw adaptability to variable CDR3 characteristics, such as length, amino acid composition and conformation.</p>
        <p>Noteworthily, when performing a similar sequence comparison for Nbs for which refolding data are available (the analysis was carried out only for llama Nbs since too little data were found for other camelid species), more variability is observed between the consensus Fw sequences of the Nb groups with low (&lt; 50%) and high (&gt; 75%) refolding ratios (<xref rid="s7" ref-type="sec">Figure S4</xref>). Interestingly, most of the observed differences correspond to solvent-accessible positions. A moderate correlation between <italic toggle="yes">T</italic><sub>m</sub> and refolding is observed (<italic toggle="yes">r</italic><sub>P</sub> = 0.63 and <italic toggle="yes">r</italic><sub>S</sub> = 0.64). However, it is difficult to draw meaningful conclusions because of the limited amount of data on folding recovery in the database.</p>
      </sec>
    </sec>
  </sec>
  <sec id="s5">
    <title>Projections</title>
    <p>The current implementation of NbThermo allows visualization and retrieval of stored data. Various filters can be applied to select sets of Nbs belonging to distinct categories or having melting temperatures within a desired range. Several features will be improved in the future, such as interactive search based on sequence identity, annotation of new entries by community contributions, artificial intelligence–based structural models and <italic toggle="yes">T</italic><sub>m</sub> prediction for new sequences.</p>
  </sec>
  <sec id="s6">
    <title>Conclusions</title>
    <p>Here, we presented NbThermo—a curated thermostability database of Nbs. The database contains up-to-date data for 564 Nbs, which were compiled from diverse sources and manually annotated to ensure maximum reliability. Our exploratory research, now using a much larger amount of data compared to previous studies, indicates that understanding the structural bases of Nb thermostability is a complex task since both the Fw and the CDR regions play significant roles and there are no evident differences in sequence patterns between the Fws of Nbs with lower and higher melting temperatures. We have put effort in compiling these data hoping to contribute to the development of new algorithms for reliable <italic toggle="yes">T</italic><sub>m</sub> prediction, as useful tools to assist Nb engineering for the wide range of applications of these unique biomolecules.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baad021_Supp</label>
      <media xlink:href="baad021_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="s7">
    <title>Supplementary material</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Database</italic> online.</p>
  </sec>
  <sec sec-type="data-availability" id="s8">
    <title>Data availability</title>
    <p>The NbThermo database is available at <ext-link xlink:href="https://valdes-tresanco-ms.github.io/NbThermo" ext-link-type="uri">https://valdes-tresanco-ms.github.io/NbThermo</ext-link>.</p>
  </sec>
  <sec id="s9">
    <title>Funding</title>
    <p>University of Medellin and MINCIENCIAS, MINEDUCACIÓN, MINCIT and ICETEX [Program NanoBioCáncer (grant number FP44842-211-2018)].</p>
  </sec>
  <sec sec-type="COI-statement" id="s10">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Audenhove</surname><given-names>I.</given-names></string-name> and <string-name><surname>Gettemans</surname><given-names>J.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Nanobodies as versatile tools to understand, diagnose, visualize and treat cancer</article-title>. <source><italic toggle="yes">EBioMedicine</italic></source>, <volume>8</volume>, <fpage>40</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">27428417</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miller</surname><given-names>T.W.</given-names></string-name> and <string-name><surname>Messer</surname><given-names>A.</given-names></string-name></person-group> (<year>2005</year>) <article-title>Intrabody applications in neurological disorders: progress and future prospects</article-title>. <source><italic toggle="yes">Mol. Ther.</italic></source>, <volume>12</volume>, <fpage>394</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">15964243</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lo</surname><given-names>A.S.Y.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Q.</given-names></string-name> and <string-name><surname>Marasco</surname><given-names>W.A.</given-names></string-name></person-group> (<year>2008</year>) <article-title>Intracellular antibodies (intrabodies) and their therapeutic potential</article-title>. <source><italic toggle="yes">Handb Exp. Pharmacol.</italic></source>, <volume>181</volume>, <fpage>343</fpage>–<lpage>373</lpage>.</mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steeland</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vandenbroucke</surname><given-names>R.E.</given-names></string-name> and <string-name><surname>Libert</surname><given-names>C.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Nanobodies as therapeutics: big opportunities for small antibodies</article-title>. <source><italic toggle="yes">Drug Discov. Today</italic></source>, <volume>21</volume>, <fpage>1076</fpage>–<lpage>1113</lpage>.<pub-id pub-id-type="pmid">27080147</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dumoulin</surname><given-names>M.</given-names></string-name>, <string-name><surname>Conrath</surname><given-names>K.</given-names></string-name>, <string-name><surname>van Meirhaeghe</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2002</year>) <article-title>Single-domain antibody fragments with high conformational stability</article-title>. <source><italic toggle="yes">Protein Sci.</italic></source>, <volume>11</volume>, <fpage>500</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">11847273</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muyldermans</surname><given-names>S.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Nanobodies: natural single-domain antibodies</article-title>. <source><italic toggle="yes">Annu. Rev. Biochem.</italic></source>, <volume>82</volume>, <fpage>775</fpage>–<lpage>797</lpage>.<pub-id pub-id-type="pmid">23495938</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kunz</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zinner</surname><given-names>K.</given-names></string-name>, <string-name><surname>Mücke</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>The structural basis of nanobody unfolding reversibility and thermoresistance</article-title>. <source><italic toggle="yes">Sci. Rep.</italic></source>, <volume>8</volume>, <fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">29311619</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valdés-Tresanco</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Molina-Zapata</surname><given-names>A.</given-names></string-name>, <string-name><surname>Pose</surname><given-names>A.G.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>Structural insights into the design of synthetic nanobody libraries</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume>27</volume>, <page-range>2198</page-range>.</mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kunz</surname><given-names>P.</given-names></string-name>, <string-name><surname>Flock</surname><given-names>T.</given-names></string-name>, <string-name><surname>Soler</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Exploiting sequence and stability information for directing nanobody stability engineering</article-title>. <source><italic toggle="yes">Biochim. Biophys. Acta Gen. Subj.</italic></source>, <volume>1861</volume>, <fpage>2196</fpage>–<lpage>2205</lpage>.<pub-id pub-id-type="pmid">28642127</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldman</surname><given-names>E.R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Zabetakis</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Enhancing stability of camelid and shark single domain antibodies: an overview</article-title>. <source><italic toggle="yes">Front. Immunol.</italic></source>, <volume>8</volume>, <page-range>865</page-range>.</mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hussack</surname><given-names>G.</given-names></string-name>, <string-name><surname>Hirama</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>W.</given-names></string-name></person-group><etal>et al.</etal> (<year>2011</year>) <article-title>Engineered single-domain antibodies with high protease resistance and thermal stability</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>6</volume>, <page-range>28218</page-range>.</mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zabetakis</surname><given-names>D.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>G.P.</given-names></string-name>, <string-name><surname>Bayya</surname><given-names>N.</given-names></string-name></person-group><etal>et al.</etal> (<year>2013</year>) <article-title>Contributions of the complementarity determining regions to the thermal stability of a single-domain antibody</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>8</volume>, <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Schittny</surname><given-names>V.</given-names></string-name> and <string-name><surname>Nash</surname><given-names>M.A.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Removal of a conserved disulfide bond does not compromise mechanical stability of a VHH antibody complex</article-title>. <source><italic toggle="yes">Nano Lett.</italic></source>, <volume>19</volume>, <fpage>5524</fpage>–<lpage>5529</lpage>.<pub-id pub-id-type="pmid">31257893</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zabetakis</surname><given-names>D.</given-names></string-name>, <string-name><surname>Olson</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>G.P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody</article-title>. <source><italic toggle="yes">PLoS One</italic></source>, <volume>9</volume>, <page-range>e115405</page-range>.</mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turner</surname><given-names>K.B.</given-names></string-name>, <string-name><surname>Zabetakis</surname><given-names>D.</given-names></string-name>, <string-name><surname>Goldman</surname><given-names>E.R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection</article-title>. <source><italic toggle="yes">Protein Eng. Des. Sel.</italic></source>, <volume>27</volume>, <fpage>89</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">24488977</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Goldman</surname><given-names>E.R.</given-names></string-name>, <string-name><surname>Zabetakis</surname><given-names>D.</given-names></string-name></person-group><etal>et al.</etal> (<year>2015</year>) <article-title>Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond</article-title>. <source><italic toggle="yes">Microb. Cell Fact.</italic></source>, <volume>14</volume>, <page-range>158</page-range>.</mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soler</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Fortuna</surname><given-names>S.</given-names></string-name>, <string-name><surname>de Marco</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2018</year>) <article-title>Binding affinity prediction of nanobody-protein complexes by scoring of molecular dynamics trajectories</article-title>. <source><italic toggle="yes">Phys. Chem. Chem. Phys.</italic></source>, <volume>20</volume>, <fpage>3438</fpage>–<lpage>3444</lpage>.<pub-id pub-id-type="pmid">29328338</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>H.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection</article-title>. <source><italic toggle="yes">Nat. Commun.</italic></source>, <volume>12</volume>, <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">33397941</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hacisuleyman</surname><given-names>A.</given-names></string-name> and <string-name><surname>Erman</surname><given-names>B.</given-names></string-name></person-group> (<year>2020</year>) <article-title>ModiBodies: a computational method for modifying nanobodies to improve their antigen binding affinity and specificity</article-title>. <source><italic toggle="yes">J. Biol. Phys.</italic></source>, <volume>46</volume>, <fpage>189</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">32418062</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Shriver-Lake</surname><given-names>L.C.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>G.P.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein</article-title>. <source><italic toggle="yes">Microb. Cell Fact.</italic></source>, <volume>16</volume>, <page-range>223</page-range>.</mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deszyński</surname><given-names>P.</given-names></string-name>, <string-name><surname>Młokosiewicz</surname><given-names>J.</given-names></string-name>, <string-name><surname>Volanakis</surname><given-names>A.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>INDI—integrated nanobody database for immunoinformatics</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>50</volume>, <fpage>D1273</fpage>–<lpage>D1281</lpage>.<pub-id pub-id-type="pmid">34747487</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dunbar</surname><given-names>J.</given-names></string-name>, <string-name><surname>Krawczyk</surname><given-names>K.</given-names></string-name>, <string-name><surname>Leem</surname><given-names>J.</given-names></string-name></person-group><etal>et al.</etal> (<year>2014</year>) <article-title>SAbDab: the structural antibody database</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>42</volume>, <fpage>D1140</fpage>–<lpage>D1146</lpage>.<pub-id pub-id-type="pmid">24214988</pub-id></mixed-citation>
    </ref>
    <ref id="R23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Raybould</surname><given-names>M.I.J.</given-names></string-name>, <string-name><surname>Kovaltsuk</surname><given-names>A.</given-names></string-name>, <string-name><surname>Marks</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2021</year>) <article-title>CoV-AbDab: the coronavirus antibody database</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>37</volume>, <fpage>734</fpage>–<lpage>735</lpage>.<pub-id pub-id-type="pmid">32805021</pub-id></mixed-citation>
    </ref>
    <ref id="R24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zuo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name></person-group><etal>et al.</etal> (<year>2017</year>) <article-title>Institute collection and analysis of nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies</article-title>. <source><italic toggle="yes">BMC Genomics</italic></source>, <volume>18</volume>, <fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">28049423</pub-id></mixed-citation>
    </ref>
    <ref id="R25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Honegger</surname><given-names>A.</given-names></string-name> and <string-name><surname>Plückthun</surname><given-names>A.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool</article-title>. <source><italic toggle="yes">J. Mol. Biol.</italic></source>, <volume>309</volume>, <fpage>657</fpage>–<lpage>670</lpage>.<pub-id pub-id-type="pmid">11397087</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dunbar</surname><given-names>J.</given-names></string-name> and <string-name><surname>Deane</surname><given-names>C.M.</given-names></string-name></person-group> (<year>2016</year>) <article-title>ANARCI: antigen receptor numbering and receptor classification</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>32</volume>, <fpage>298</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">26424857</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kinoshita</surname><given-names>S.</given-names></string-name>, <string-name><surname>Nakakido</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mori</surname><given-names>C.</given-names></string-name></person-group><etal>et al.</etal> (<year>2022</year>) <article-title>Molecular basis for thermal stability and affinity in a VHH: contribution of the framework region and its influence in the conformation of the CDR3</article-title>. <source><italic toggle="yes">Protein Sci.</italic></source>, <volume>31</volume>, <page-range>e4450</page-range>.</mixed-citation>
    </ref>
  </ref-list>
</back>
